A

Amerisourcebergen Corp
LSE:0HF3

Watchlist Manager
Amerisourcebergen Corp
LSE:0HF3
Watchlist
Price: 237.12 USD -0.01% Market Closed
Market Cap: 49.1B USD
Have any thoughts about
Amerisourcebergen Corp?
Write Note

Amerisourcebergen Corp
Retained Earnings

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Amerisourcebergen Corp
Retained Earnings Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Retained Earnings CAGR 3Y CAGR 5Y CAGR 10Y
A
Amerisourcebergen Corp
LSE:0HF3
Retained Earnings
$5.4B
CAGR 3-Years
48%
CAGR 5-Years
5%
CAGR 10-Years
13%
Cardinal Health Inc
NYSE:CAH
Retained Earnings
$14m
CAGR 3-Years
-78%
CAGR 5-Years
-48%
CAGR 10-Years
-44%
Henry Schein Inc
NASDAQ:HSIC
Retained Earnings
$3.8B
CAGR 3-Years
2%
CAGR 5-Years
5%
CAGR 10-Years
4%
Patterson Companies Inc
NASDAQ:PDCO
Retained Earnings
$775.5m
CAGR 3-Years
-4%
CAGR 5-Years
-12%
CAGR 10-Years
-7%
Mckesson Corp
NYSE:MCK
Retained Earnings
$16B
CAGR 3-Years
22%
CAGR 5-Years
6%
CAGR 10-Years
3%
Cencora Inc
NYSE:COR
Retained Earnings
$5.4B
CAGR 3-Years
48%
CAGR 5-Years
5%
CAGR 10-Years
13%
No Stocks Found

Amerisourcebergen Corp
Glance View

Economic Moat
None
Market Cap
46.2B USD
Industry
Health Care

AmerisourceBergen Corp., a titan in the realm of pharmaceutical services, orchestrates the flow of medications across a vast and intricate network. Rooted in Chesterbrook, Pennsylvania, the company has cemented its place as a critical link in the healthcare supply chain. Serving as a bridge between pharmaceutical manufacturers and a wide array of healthcare providers like hospitals, clinics, and pharmacies, AmerisourceBergen leverages its expansive distribution infrastructure to ensure that medications and health products reach their destinations efficiently and reliably. The company's operations are bolstered by its strategic partnerships and collaboration with a plethora of healthcare entities, enabling it to integrate seamlessly into the delivery systems that support patient care. At its core, AmerisourceBergen turns the complexity of healthcare logistics into a streamlined process, generating revenue primarily through the distribution of pharmaceuticals. It purchases medications from manufacturers, sells them at a markup to healthcare providers, and in doing so, balances a robust supply chain fueled by efficiency and scale. But the story doesn't end at distribution; the company has expanded its reach through value-added services such as consulting, data analytics, and patient support services that further solidify its role in the healthcare ecosystem. Whether navigating regulatory environments or advising on patient care strategies, AmerisourceBergen positions itself as not just a distributor, but a partner in health. Through this dual approach of distribution and strategic services, the company ensures it remains vital to both manufacturers and healthcare providers, creating a sustainable business model that capitalizes on both volume and innovation.

0HF3 Intrinsic Value
434.05 USD
Undervaluation 45%
Intrinsic Value
Price
A

See Also

What is Amerisourcebergen Corp's Retained Earnings?
Retained Earnings
5.4B USD

Based on the financial report for Sep 30, 2024, Amerisourcebergen Corp's Retained Earnings amounts to 5.4B USD.

What is Amerisourcebergen Corp's Retained Earnings growth rate?
Retained Earnings CAGR 10Y
13%

Over the last year, the Retained Earnings growth was 25%. The average annual Retained Earnings growth rates for Amerisourcebergen Corp have been 48% over the past three years , 5% over the past five years , and 13% over the past ten years .

Back to Top